LRLCY Stock Recent News
LRLCY LATEST HEADLINES
CNBC's Charlotte Reed takes an exclusive tour of L'Oreal's new research and innovation center in Clark, New Jersey, as she learns about the latest technology developments at the world's largest cosmetics company.
L'Oréal S.A. (OTCPK:LRLCF) Q1 2025 Sales/ Trading Statement Call April 17, 2025 12:30 PM ET Company Participants Eva Quiroga - Head of IR Nicolas Hieronimus - CEO Christophe Babule - CFO Laurent Schmitt - Global Head of Corporate Finance and Financial Communications Conference Call Participants Guillaume Delmas - UBS Charles Scotti - Kepler Cheuvreux Celine Pannuti - JPMorgan Jeremy Failko - HSBC Olivier Nicolai - Goldman Sachs Sarah Simon - Morgan Stanley Tom Sykes - Deutsche Bank Ashley Wallace - Bank of America Operator Welcome to the conference call regarding L'Oreal sales at 31st of March 2025.
L'Oréal Chief Executive Nicolas Hieronimus said he is optimistic on the outlook for the global beauty market despite economic and geopolitical tensions.
Investors looking for stocks in the Consumer Products - Staples sector might want to consider either Sony (SONY) or L'Oreal SA (LRLCY). But which of these two stocks is more attractive to value investors?
The world's largest beauty company, L'Oreal, has invested $160 million to revamp its North America Research & Innovation Center, its largest investment in R&I in its 110 years history, located in Clark, New Jersey.
Hieronimus said he is "not overly concerned" over the impact of White House tariffs on L'Oreal, as the group produces most of its goods sold in the U.S. in the North American country. Some of the cosmetics titan's luxury products, such as fragrances, are nevertheless exported from Europe.
Makeup company L'Oréal S.A. issued a recall on all lots of acne cream Effaclar Duo due to concern that benzene, a known carcinogen, is in the product.
L'Oreal CEO Nicolas Hieronimus discusses the U.S. market, tariffs, European competitiveness and Chinese demand in an exclusive interview at the firm's newly opened R&I facility in New Jersey.
L'Oreal CEO Nicolas Hieronimus discusses the company's $160 million investment in its new U.S. R&I facility in an exclusive interview with CNBC.
The Rip Van Winkle portfolio advocates for long-term, buy-and-hold investing in companies with competitive advantages, reasonable valuations, and strong financial performance. Alphabet, Meta, and Alibaba dominate the tech sector, benefiting from digital advertising, AI, and Cloud growth. Novo Nordisk and L'Oréal capitalize on secular trends in health and personal care, offering stability and growth potential in a long-term portfolio.